These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21462154)

  • 1. Lens opacities in Valencia, Spain.
    Díez-Ajenjo MA; García-Domene MC; Artigas JM; Felipe A; Peris-Martínez C; Menezo JL
    Eur J Ophthalmol; 2011; 21(6):715-22. PubMed ID: 21462154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liées à l'Age (POLA) study.
    Delcourt C; Carrière I; Ponton-Sanchez A; Lacroux A; Covacho MJ; Papoz L
    Arch Ophthalmol; 2000 Mar; 118(3):385-92. PubMed ID: 10721962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of lens opacities in the Italian-American Case-Control Study of Age-Related Cataract. The Italian-American Study Group.
    Maraini G; Pasquini P; Sperduto RD; Rosmini F; Bonacini M; Tomba MC; Corona R
    Ophthalmology; 1990 Jun; 97(6):752-6. PubMed ID: 2374679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification system for cataracts. Application by the Japanese Cooperative Cataract Epidemiology Study Group.
    Sasaki K; Shibata T; Obazawa H; Fujiwara T; Kogure F; Obara Y; Itoi M; Katou K; Akiyama K; Okuyama S
    Ophthalmic Res; 1990; 22 Suppl 1():46-50. PubMed ID: 2388751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cataract severity and morphology on the reliability of the Lens Opacities Classification System II (LOCS II).
    Maraini G; Pasquini P; Sperduto RD; Bonacini M; Carrieri MP; Corona R; Graziosi P; Tomba MC; Williams SL
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2400-3. PubMed ID: 2071351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of cataract in 35-64 years old Kaunas city population].
    Bojarskiene F; Paunksnis A
    Medicina (Kaunas); 2005; 41(9):774-80. PubMed ID: 16227710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33.
    Koo E; Chang JR; Agrón E; Clemons TE; Sperduto RD; Ferris FL; Chew EY;
    Ophthalmic Epidemiol; 2013 Apr; 20(2):71-81. PubMed ID: 23510310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and progression of cortical, nuclear, and posterior subcapsular cataracts. The Italian-American Cataract Study Group.
    Am J Ophthalmol; 1994 Nov; 118(5):623-31. PubMed ID: 7977575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cataract in central Sri Lanka: prevalence and risk factors from the Kandy Eye Study.
    Athanasiov PA; Edussuriya K; Senaratne T; Sennanayake S; Sullivan T; Selva D; Casson RJ
    Ophthalmic Epidemiol; 2010; 17(1):34-40. PubMed ID: 20100098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading nuclear, cortical and posterior subcapsular cataracts using an objective scatter index measured with a double-pass system.
    Vilaseca M; Romero MJ; Arjona M; Luque SO; Ondategui JC; Salvador A; Güell JL; Artal P; Pujol J
    Br J Ophthalmol; 2012 Sep; 96(9):1204-10. PubMed ID: 22790434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skövde cataract study: I. Prevalence of lens opacities in a Swedish community.
    Ostberg A; Löth A; Gustafson D; Lindblom B
    Ophthalmology; 2006 Jun; 113(6):970-5. PubMed ID: 16751038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Casteldaccia eye study: prevalence of cataract in the adult and elderly population of a Mediterranean town.
    Giuffrè G; Giammanco R; Di Pace F; Ponte F
    Int Ophthalmol; 1994-1995; 18(6):363-71. PubMed ID: 7642339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of lens opacities in Latinos: the Los Angeles Latino Eye Study.
    Varma R; Torres M;
    Ophthalmology; 2004 Aug; 111(8):1449-56. PubMed ID: 15288970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between Aqueous Connective Tissue Growth Factor and the Severity of Age-related Cataracts as Graded by the Lens Opacities Classification System III.
    Hwang HB; Yim HB; Cho YK; Choi JA
    Curr Eye Res; 2016; 41(3):350-6. PubMed ID: 26301961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of cataract in rural Indonesia.
    Husain R; Tong L; Fong A; Cheng JF; How A; Chua WH; Lee L; Gazzard G; Tan DT; Koh D; Saw SM
    Ophthalmology; 2005 Jul; 112(7):1255-62. PubMed ID: 15993241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of nuclear, cortical, and posterior subcapsular lens opacities in a general population sample.
    Sperduto RD; Hiller R
    Ophthalmology; 1984 Jul; 91(7):815-8. PubMed ID: 6472815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for lens opacities in Nigeria: results of the national blindness and low vision survey.
    Mahdi AM; Rabiu M; Gilbert C; Sivasubramaniam S; Murthy GV; Ezelum C; Entekume G;
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2642-51. PubMed ID: 24526441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senile cataract progression studies using the Lens Opacities Classification System II.
    Magno BV; Datiles MB; Lasa SM
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):2138-41. PubMed ID: 8491564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship between ingested arsenic and cataracts among residents in Southwestern Taiwan.
    See LC; Chiou HY; Lee JS; Hsueh YM; Lin SM; Tu MC; Yang ML; Chen CJ
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Oct; 42(12):1843-51. PubMed ID: 17952785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Reykjavik Eye Study--prevalence of lens opacification with reference to identical Japanese studies.
    Sasaki H; Jonasson F; Kojima M; Katoh N; Ono M; Takahashi N; Sasaki K
    Ophthalmologica; 2000; 214(6):412-20. PubMed ID: 11054002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.